Passer au contenu principal

Votre navigateur n’est malheureusement pas entièrement pris en charge. Si vous avez la possibilité de le faire, veuillez passer à une version plus récente ou utiliser Mozilla Firefox, Microsoft Edge, Google Chrome, ou Safari 14 ou plus récent. Si vous n’y parvenez pas et que vous avez besoin d’aide, veuillez nous faire part de vos commentaires.

Nous vous serions reconnaissants de nous faire part de vos commentaires sur cette nouvelle expérience.Faites-nous part de votre opinion S’ouvre dans une nouvelle fenêtre

Elsevier
Publier avec nous

Participate

Abstract Submission Deadline: 2 May 2025

Oral and paper abstracts are now invited on the following topics. They should be submitted using the online abstract submission system S’ouvre dans une nouvelle fenêtre.

Conference Topics

  • Systems Vaccinology

  • Vaccines against STIs

  • Models for Vaccine Development and Evaluation

  • Immunization of Special Risk Groups and/or Maternal Immunization

  • Veterinary Vaccines

  • Vaccines against Respiratory Diseases (Influenza/Covid/RSV): Focus on Mucosal Vaccines

  • Social and Political Impacts of Vaccination and Vaccine Policy

  • Vaccines for Emerging Pathogens and One Health

  • Vaccines for Neglected Diseases

  • Vaccine Durability, Formulation and Administration

  • Vaccine Production and Process Technology

  • Hot Topics: SFTSV, Marburg, mpox, etc.

You can submit as many abstracts to the conference for review as you would like.  If, after the review by the committee, you have more than one paper accepted for the conference, you will need to register to attend and pay an additional paper fee for each additional paper (i.e., for the 2nd, 3rd, 4th papers – not the 1st). Please note this is for papers that you are the presenting author of, not papers that you are co-author of.

Successfully submitted abstracts will be acknowledged with an electronic receipt including an abstract reference number, which should be quoted in all correspondence. Allow at least 2 hours for your receipt to be returned to you.

For revisions or queries regarding papers already submitted

For revisions or queries regarding abstracts already submitted please contact the Conference Content Executive S’ouvre dans une nouvelle fenêtre, (please do not email credit card information under any circumstances). If you do not receive acknowledgement for your abstract submission or you wish to make any essential revisions to an abstract already submitted, please DO NOT RESUBMIT your abstract, as this may lead to duplication. Please email the Conference Content Executive S’ouvre dans une nouvelle fenêtre (please do not email credit card information under any circumstances) with details of any revisions or queries. Please quote your reference number if you have one. A condition of submission is that if accepted one of the authors will present at the conference.

Awards

Schneerson Robbins Award

Rachel Schneerson and John Robbins are known for their groundbreaking work and bold, visionary and imaginative leadership in the development and commercialization of the Hemophilus influenzae type b vaccine and bringing the vaccine to market, leading to the eradication of Hemophilus influenzae type b, typhoid, and pneumococcus.

https://www.aai.org/About/History/Notable-Members/Lasker-Awardees/Rachel-Schneerson#gsc.tab=0 S’ouvre dans une nouvelle fenêtre

The purpose of the award is to recognise an outstanding scientist in the field of Bacterial Vaccines.

The nomination should contain the name of your nominee, his/her CV, and a summary of his/her scientific merit and research impact. Unfortunately self-nominations cannot be accepted.

Please send nominations to Cinzia Mamberti, Conference Project Lead S’ouvre dans une nouvelle fenêtre with the subject heading “Vaccine 2025 - Schneerson Robbins Award”.

Deadline for nominations: 21 February 2025

The winner of the 2025 award will be invited to give a 20-minute Keynote lecture at the 19th Vaccine Congress in Kyoto, Japan, 7 – 10 September 2025. Registration will be complementary and a contribution towards flight and accommodation at the conference will also be provided.

The selected nominee will be contacted by the Organisers by 7 March 2025.

Previous recipients of the award:

  • 2024: Galit Alter Moderna, USA

  • 2023: Maria Elena Bottazzi, Baylor College of Medicine, USA

  • 2022: Rino Rappuoli, GlaxoSmithKline Vaccines, Italy

  • 2019: Kathryn M. Edwards, Director, Vanderbilt Vaccine Research Program, Vanderbilt University School of Medicine, USA

  • 2018: Carol J. Baker, University of Texas Health Science Center, USA

  • 2017: Rachel Schneerson, National Institutes of Health, USA

Jenner Award

Edward Jenner was an English doctor, the pioneer of smallpox vaccination and the father of immunology.

https://www.bbc.co.uk/history/historic_figures/jenner_edward.shtml S’ouvre dans une nouvelle fenêtre

The purpose of the award is to recognise an outstanding scientist in the field of Vaccinology.

The nomination should contain the name of your nominee, his/her CV, and a summary of his/her scientific merit and research impact. Unfortunately self-nominations cannot be accepted.

Please send nominations to Cinzia Mamberti, Conference Project Lead S’ouvre dans une nouvelle fenêtre with the subject heading “Vaccine 2025 - Jenner Award”.

Deadline for nominations: 21 February 2025

The winner of the 2025 award will be invited to give a 20-minute Keynote lecture at the 19th Vaccine Congress in Kyoto, Japan, 7 – 10 September 2025. Registration will be complementary and a contribution towards flight and accommodation at the conference will also be provided.

The selected nominee will be contacted by the Organisers by 7 March 2025.

Previous recipients of the award:

  • 2024: Kathleen Neuzil, Fogarty International Center, NIH, USA

  • 2023: Robin Shattock, Imperial College London, UK

  • 2022: Myron Levin, University of Colorado, USA

  • 2019: Rino Rappuoli, Chief Scientist & Head of External Research and Development, GlaxoSmithKline Vaccines, USA

  • 2018: Stanley A. Plotkin, University of Pennsylvania & Vaxconsult, USA

  • 2017: John B Robbins, National Institutes of Health, USA

Early Career Researcher Award

The ECR Award will be presented to an exceptional young researcher in the field of Vaccines, ideally within the first 5 years of their career.

The nomination should contain a recent CV and a letter of support from an established colleague or professor. We are pleased to accept self-nominations for this award.

Please send nominations to Cinzia Mamberti, Conference Project Lead S’ouvre dans une nouvelle fenêtre with the subject heading “Vaccine 2025 - ECR Award”.

Deadline for nominations: 21 February 2025

The winner of the 2025 award will be invited to give a 20-minute Keynote lecture at the 19th Vaccine Congress in Kyoto, Japan, 7 – 10 September 2025. Registration will be complementary and a contribution towards flight and accommodation at the conference will also be provided.

The selected nominee will be contacted by the Organisers by 7 March 2025.

Previous recipients of the award:

  • 2024: David Martinez, Yale University School of Medicine, USA

  • 2022: Daniela Weiskopf, La Jolla Institute for Immunology, USA

Host Country Early Career Researcher Award

The ECR Award will be presented to an exceptional young researcher in the field of Vaccines and based in Japan, host country of the Vaccine 2025 Conference, ideally within the first 5 years of their career.

The nomination should contain a recent CV and a letter of support from an established colleague or professor. We are pleased to accept self-nominations for this award.

Please send nominations to Cinzia Mamberti, Conference Project Lead S’ouvre dans une nouvelle fenêtre with the subject heading “Vaccine 2025 – Host Country ECR Award”.

Deadline for nominations: 21 February 2025

The winner of the 2025 award will be invited to give a 20-minute Keynote lecture at the 19th Vaccine Congress in Kyoto, Japan, 7 – 10 September 2025. Registration will be complementary and a contribution towards flight and accommodation at the conference will also be provided.

The selected nominee will be contacted by the Organisers by 7 March 2025.